Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income (Loss) [Member]
Balance at Dec. 31, 2023	$ 484,994	$ 20	$ 839,014	$ (352,073)	$ (1,967)
Balance (in shares) at Dec. 31, 2023		206,611,704
Net loss	(39,592)	$ 0	0	(39,592)	0
Other comprehensive income (loss)	247	0	0	0	247
Issuance of common stock from equity incentive plans	11,929	$ 1	11,928	0	0
Issuance of common stock from equity incentive plans (in shares)		4,184,593
Vesting of restricted common stock	98	$ 0	98	0	0
Vesting of restricted common stock (in shares)		48,145
Stock-based compensation	22,093	$ 0	22,093	0	0
Balance at Mar. 31, 2024	479,769	$ 21	873,133	(391,665)	(1,720)
Balance (in shares) at Mar. 31, 2024		210,844,442
Balance at Dec. 31, 2024	383,862	$ 22	1,067,403	(683,720)	157
Balance (in shares) at Dec. 31, 2024		221,919,191
Net loss	(32,252)	$ 0	0	(32,252)	0
Other comprehensive income (loss)	(168)	$ 0	0	0	(168)
Issuance of common stock in connection with at-the-market offering, net of issuance costs (in shares)		16,038,460
Issuance of common stock in connection with at-the-market offering, net of issuance costs	358,255	$ 2	358,253	0	0
Issuance of common stock from equity incentive plans	8,181	$ 0	8,181	0	0
Issuance of common stock from equity incentive plans (in shares)		4,654,283
Vesting of restricted common stock	98	$ 0	98	0	0
Vesting of restricted common stock (in shares)		48,145
Stock-based compensation	31,417	$ 0	31,417	0	0
Warrants exercised shares		408,838
Warrants exercised	15,655	$ 0	15,655	0
Balance at Mar. 31, 2025	$ 765,048	$ 24	$ 1,481,007	$ (715,972)	$ (11)
Balance (in shares) at Mar. 31, 2025		243,068,917